𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Individualizing hepatitis B infection prophylaxis in liver transplant recipients

✍ Scribed by Alyson N. Fox; Norah A. Terrault

Book ID
116652477
Publisher
Elsevier Science
Year
2011
Tongue
English
Weight
221 KB
Volume
55
Category
Article
ISSN
0168-8278

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Hepatitis B in liver transplant recipien
Hepatitis B in liver transplant recipients
✍ Robert G. Gish; Timothy McCashland πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 188 KB πŸ‘ 1 views

1. The use of low-dose immunosuppressive therapy along with pre- and posttransplantation nucleos(t)ide therapy and posttransplantation hepatitis B immunoglobulin (HBIG) has yielded marked improvements in survival. 2. Lamivudine (Epivir-HBV), adefovir (Hepsera), entecavir (Baraclude), tenofovir (Vire

Ganciclovir treatment of hepatitis B vir
Ganciclovir treatment of hepatitis B virus infection in liver transplant recipients
✍ R G Gish; J Y Lau; L Brooks; J W S Fang; S L Steady; J C Imperial; R Garcia-Kenn πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 366 KB πŸ‘ 2 views

To determine the safety and efficacy of ganciclovir usually experience progressive liver disease over an treatment of hepatitis B virus (HBV) infection after liver accelerated time course and pose a difficult managetransplantation, nine patients (seven males, two females; ment challenge. The treatm

Treating hepatitis C infection in liver
Treating hepatitis C infection in liver transplant recipients
✍ Norah A. Terrault; Marina Berenguer πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 192 KB πŸ‘ 1 views

Chronic infection with hepatitis C virus (HCV) is a growing problem worldwide, with up to 300 million individuals infected, and those with chronic infection are at risk for cirrhosis and hepatocellular carcinoma. HCV infection is the most common indication for liver transplantation in the United Sta